Key market opportunities include the rising demand for AI-enhanced trial design, boosted by increasing complexity in clinical ...

Details of the model, called Path-IO, were presented today at the American Association for Cancer Research (AACR) Annual ...

Stanford Medicine has developed a vision-language artificial intelligence (AI) model that can predict cancer outcomes, such as forecasting melanoma relapses and patient responses to immunotherapy.

PITTSBURGH, May 22, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) moves to leverage its vast biobank of more than 150,000 heterogenous live cell tumor samples and drug response data ...

A deep learning platform may help predict how people with advanced lung cancer will respond to immunotherapy, according to ...

PITTSBURGH, April 15, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today that it has made significant progress along the continuum ...

Forbes contributors publish independent expert analyses and insights. David Henkin helps organizations and individuals innovate and grow. Predictive analytics has evolved from a niche discipline into ...

PITTSBURGH, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology (POAI), an AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH, the ...